Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 33.56 | 18.82 |
| PEG Ratio (TTM) | 6.26 | -0.07 |
| P/S Ratio (TTM) | 2.95 | 0.55 |
| P/B Ratio (TTM) | 6.63 | 1.40 |
| P/FCF Ratio (TTM) | 27.91 | 13.50 |
| Price to 5YR AVG Earnings Ratio | 173.89 | 15.48 |
| Price to 5YR AVG FCF Ratio | 734.02 | 62.46 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 14.51% | 4.37% |
| ROE (TTM) | 22.29% | 9.38% |
| Net Profit Margin (TTM) | 8.68% | 1.13% |
| ROIC 5YR AVG | 9.61% | 12.07% |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 38.12% | 32.00% | 389.92% |
| Revenue | 7.48% | 35.30% | 35.00% |
| Net Income | 38.68% | 16.81% | 389.12% |
| Cash Flow | 29.28% | 70.44% | 158.07% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.24 | 1.99 |
| Quick Ratio (TTM) | 2.81 | 1.18 |
| D/E Ratio (TTM) | N/A | 0.52 |
| Interest Coverage (TTM) | 57.35 | 4.33 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 14.35 | 3.93 |
| LTL to 5YR AVG FCF | 7.02 | 18.32 |
| Shares Outstanding Growth 5YR AVG | 5.30% | 0.90% |